Keyphrases
Patients with Breast Cancer
100%
3-Hydroxypropyl Mercapturic Acid
100%
Cyclophosphamide Toxicity
100%
Hematuria
60%
Cyclophosphamide
50%
Acid Concentration
30%
Creatinine
30%
Acrolein
30%
Formic Acid
20%
Analytical Method
10%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
10%
Mobile Phase
10%
Cancer Types
10%
In(III)
10%
Linear Response
10%
Acidification
10%
Metabolism
10%
Acetonitrile
10%
Bladder
10%
Urine Samples
10%
Concentration of Measure
10%
N-acetylcysteine
10%
Chemotherapy Regimen
10%
Electrospray Ionization
10%
Reversed Phase
10%
FDA Guidance
10%
Alkylating Agents
10%
Human Urine
10%
Toxic Side Effects
10%
Mass Spectrometer
10%
Positive Ion Mode
10%
Hemorrhagic Cystitis
10%
Bladder Cancer
10%
Multiple Reaction Monitoring Mode
10%
Triple Quadrupole
10%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Cyclophosphamide
100%
Acetylcysteine
100%
Hematuria
54%
Creatinine
27%
Acrolein
27%
Formate
18%
Side Effect
9%
Biological Marker
9%
Malignant Neoplasm
9%
Acetonitrile
9%
Electrospray Ionization
9%
Chemotherapy Regimens
9%
Bladder Cancer
9%
Alkylating Agent
9%
Hemorrhagic Cystitis
9%
Chemistry
Cyclophosphamide
100%
Creatinine
50%
Acrolein
50%
Formic Acid
33%
Tandem Mass Spectrometry
16%
Metabolite
16%
Mobile Phase Composition
16%
Electrospray Ionization
16%
Liquid Chromatography Mass Spectrometry
16%
Biological Marker
16%
Toxic
16%
Acetonitrile
16%
Dilution
16%
Acidification
16%
Alkylating Agent
16%
Acetylcysteine
16%
Quadrupole
16%
Positive Ion
16%
Biochemistry, Genetics and Molecular Biology
Cyclophosphamide
100%
Creatinine
50%
Acrolein
50%
Liquid Chromatography-Mass Spectrometry
16%
Tandem Mass Spectrometry
16%
Mobile Phase Composition
16%
Electrospray Ionization
16%
Dilution
16%
Metabolic Pathway
16%
Metabolite
16%
Urine Sampling
16%
Acetylcysteine
16%
Analytical Method
16%